CCL2 and melanoma: Endothelium-specific CCL2-deficient mice (Tek-CreERT2;Ccl2flox/flox mice, herein referred to as EC-Ccl2-KO mice) did not show any differences in tumor growth when injected with B16-F10 melanoma cells (Fig. 8 a).